Merck at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
Merck at ASCO 2027 in Chicago: Booth 14013.
| Organization | ASCO 2027 Attendance |
|---|---|
Merck Rahway, NJ | |
Global drugmaker behind the PD-1 antibody pembrolizumab (Keytruda), with cancer trials in over 30 tumor types and a growing ADC pipeline. | Booth Exhibiting at Booth 14013 |
Instantly find 20 buyers from Merck
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction